News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Etubics Awarded Grant from the National Institutes of Health (NIH) for Continued Development of HIV Vaccine


8/23/2007 11:37:46 AM

SEATTLE--(BUSINESS WIRE)--Etubics Corporation, a Seattle-based biopharmaceutical company, has announced that it has received a Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) in the amount of $600,000. The grant will be used to expand Etubics’ next generation HIV vaccine into the immune targets Pol and Nef.

Read at BioSpace.com

comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES